Middle East & Africa Drug Discovery Informatics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow (Discovery Informatics and Drug Development), Service (Sequence Analysis Platform, Molecular Modelling, Clinical Trial Data Management, Docking, and Others), Solutions (Software and Services), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Others)
The Middle East and Africa Drug Discovery Informatics Market is poised for significant growth, projected to reach approximately US$ 273.7 million by 2031, up from US$ 144.0 million in 2024. This growth trajectory indicates a compound annual growth rate (CAGR) of 9.9% from 2025 to 2031, reflecting the increasing importance of informatics in drug discovery across the region.
Executive Summary and Market Analysis
The drug discovery informatics landscape in the Middle East and Africa is characterized by promising yet uneven growth, with advancements primarily concentrated in the Gulf Cooperation Council (GCC) countries. Notably, Saudi Arabia has made substantial investments in healthcare AI, channeling $1.5 billion into its National Transformation Program since 2021. This initiative includes the establishment of a bioinformatics center at the King Abdullah University of Science and Technology, aimed at enhancing the country’s capabilities in drug discovery.
In the United Arab Emirates (UAE), approximately 60% of pharmaceutical manufacturers are now leveraging predictive analytics, facilitated by the cloud computing infrastructure provided by the Dubai Health Authority. Meanwhile, South Africa's Department of Science and Innovation has allocated ZAR 450 million towards digital health initiatives in 2023, indicating a commitment to advancing healthcare technology. However, it is important to note that sub-Saharan Africa collectively invests less than 0.5% of its GDP in pharmaceutical research and development, highlighting a significant gap in funding and resources.
Israel stands out as a leader in the region, with its Office of the Chief Scientist supporting over 50 AI-driven drug discovery startups, showcasing the potential for innovation in this sector. Despite these advancements, the region faces considerable challenges, including data standardization and infrastructure limitations. Nevertheless, strategic partnerships with global pharmaceutical companies and initiatives like Qatar's precision medicine program signal a growing potential for drug discovery informatics in the region.
Market Segmentation Analysis
The Middle East and Africa Drug Discovery Informatics Market can be segmented based on various criteria:
The integration of artificial intelligence (AI) and machine learning (ML) into drug discovery informatics is revolutionizing the pharmaceutical industry. These technologies enhance data processing capabilities, enabling researchers to analyze complex biological, chemical, and clinical datasets efficiently. AI and ML algorithms can uncover hidden patterns, predict molecular interactions, and optimize compound screening, thereby accelerating the drug discovery process.
By automating repetitive tasks such as data cleaning and molecular docking, AI-driven platforms allow researchers to focus on strategic scientific inquiries and decision-making. Furthermore, predictive analytics models enhance the accuracy of candidate selection, which is crucial in reducing costly late-stage failures that have historically plagued drug development pipelines.
Pharmaceutical companies that invest in AI and ML technologies are gaining a competitive edge through shorter discovery timelines and improved precision in targeting disease pathways. This leads to the development of more effective drug candidates and personalized treatment options tailored to individual patient profiles. The ability of AI to rapidly integrate and interpret multi-omics data further facilitates the discovery of novel biomarkers and therapeutic targets.
Country Insights
When examining the market by country, Saudi Arabia emerges as a key player, holding the largest market share in 2024. The growth of the drug discovery informatics market in Saudi Arabia is closely linked to the country's 'Vision 2030' initiative, which aims to diversify the economy and enhance the healthcare sector. The government has significantly increased its research and development spending, reaching SAR 19.2 billion in 2022, which is driving the demand for advanced informatics tools to support the development of a domestic pharmaceutical industry. Historically reliant on imported drugs, Saudi Arabia is now focused on increasing local production, with a target of producing 40% of all drugs domestically. This shift is a major catalyst for the adoption of informatics solutions to streamline research and development processes, manage clinical trials, and optimize manufacturing operations.
Company Profiles
Key players in the Drug Discovery Informatics Market include Dassault Syst?mes SE, Eurofins Scientific SE, Charles River Laboratories International Inc, Jubilant Pharma Limited, Revvity Inc, Thermo Fisher Scientific Inc., Certera, Selvita, Collaborative Drug Discovery, Inc., and Illumina, Inc. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to their customers.
Executive Summary and Market Analysis
The drug discovery informatics landscape in the Middle East and Africa is characterized by promising yet uneven growth, with advancements primarily concentrated in the Gulf Cooperation Council (GCC) countries. Notably, Saudi Arabia has made substantial investments in healthcare AI, channeling $1.5 billion into its National Transformation Program since 2021. This initiative includes the establishment of a bioinformatics center at the King Abdullah University of Science and Technology, aimed at enhancing the country’s capabilities in drug discovery.
In the United Arab Emirates (UAE), approximately 60% of pharmaceutical manufacturers are now leveraging predictive analytics, facilitated by the cloud computing infrastructure provided by the Dubai Health Authority. Meanwhile, South Africa's Department of Science and Innovation has allocated ZAR 450 million towards digital health initiatives in 2023, indicating a commitment to advancing healthcare technology. However, it is important to note that sub-Saharan Africa collectively invests less than 0.5% of its GDP in pharmaceutical research and development, highlighting a significant gap in funding and resources.
Israel stands out as a leader in the region, with its Office of the Chief Scientist supporting over 50 AI-driven drug discovery startups, showcasing the potential for innovation in this sector. Despite these advancements, the region faces considerable challenges, including data standardization and infrastructure limitations. Nevertheless, strategic partnerships with global pharmaceutical companies and initiatives like Qatar's precision medicine program signal a growing potential for drug discovery informatics in the region.
Market Segmentation Analysis
The Middle East and Africa Drug Discovery Informatics Market can be segmented based on various criteria:
- By Workflow: The market is divided into Discovery Informatics and Drug Development, with the Discovery Informatics segment leading in 2024.
- By Service: Key services include Sequence Analysis Platform, Molecular Modelling, Clinical Trial Data Management, Docking, and others, with Sequence Analysis Platform being the dominant service in 2024.
- By Solutions: The market is categorized into Software and Services, where the Software segment held the largest share in 2024.
- By End User: The primary end users are Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and others, with Pharmaceutical and Biotechnology Companies being the leading segment in 2024.
The integration of artificial intelligence (AI) and machine learning (ML) into drug discovery informatics is revolutionizing the pharmaceutical industry. These technologies enhance data processing capabilities, enabling researchers to analyze complex biological, chemical, and clinical datasets efficiently. AI and ML algorithms can uncover hidden patterns, predict molecular interactions, and optimize compound screening, thereby accelerating the drug discovery process.
By automating repetitive tasks such as data cleaning and molecular docking, AI-driven platforms allow researchers to focus on strategic scientific inquiries and decision-making. Furthermore, predictive analytics models enhance the accuracy of candidate selection, which is crucial in reducing costly late-stage failures that have historically plagued drug development pipelines.
Pharmaceutical companies that invest in AI and ML technologies are gaining a competitive edge through shorter discovery timelines and improved precision in targeting disease pathways. This leads to the development of more effective drug candidates and personalized treatment options tailored to individual patient profiles. The ability of AI to rapidly integrate and interpret multi-omics data further facilitates the discovery of novel biomarkers and therapeutic targets.
Country Insights
When examining the market by country, Saudi Arabia emerges as a key player, holding the largest market share in 2024. The growth of the drug discovery informatics market in Saudi Arabia is closely linked to the country's 'Vision 2030' initiative, which aims to diversify the economy and enhance the healthcare sector. The government has significantly increased its research and development spending, reaching SAR 19.2 billion in 2022, which is driving the demand for advanced informatics tools to support the development of a domestic pharmaceutical industry. Historically reliant on imported drugs, Saudi Arabia is now focused on increasing local production, with a target of producing 40% of all drugs domestically. This shift is a major catalyst for the adoption of informatics solutions to streamline research and development processes, manage clinical trials, and optimize manufacturing operations.
Company Profiles
Key players in the Drug Discovery Informatics Market include Dassault Syst?mes SE, Eurofins Scientific SE, Charles River Laboratories International Inc, Jubilant Pharma Limited, Revvity Inc, Thermo Fisher Scientific Inc., Certera, Selvita, Collaborative Drug Discovery, Inc., and Illumina, Inc. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to their customers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DRUG DISCOVERY INFORMATICS MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 End-Use Industry
4.3.5 List of Vendors in the Value Chain
5. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DRUG DISCOVERY INFORMATICS MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS
6.1 Middle East and Africa Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East and Africa Drug Discovery Informatics Market Forecast and Analysis
7. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY WORKFLOW
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SERVICE
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SOLUTIONS
9.1 Software
9.1.1 Overview
9.1.2 Software: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET - COUNTRY ANALYSIS
11.1 Middle East and Africa
11.1.1 Middle East and Africa Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Middle East and Africa Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.1.2.2.2 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.1.2.2.3 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.1.2.2.4 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.2.3.3 South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.2.3.3.2 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.2.3.3.3 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.2.3.3.4 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.3.4.4 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.3.4.4.2 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.3.4.4.3 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.3.4.4.4 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.4.5.5 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.4.5.5.2 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.4.5.5.3 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.4.5.5.4 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Dassault Systemes SE
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eurofins Scientific SE
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Jubilant Pharma Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Certera
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Selvita
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Collaborative Drug Discovery, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. DRUG DISCOVERY INFORMATICS MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors or Suppliers
4.3.4 End-Use Industry
4.3.5 List of Vendors in the Value Chain
5. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. DRUG DISCOVERY INFORMATICS MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS
6.1 Middle East and Africa Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East and Africa Drug Discovery Informatics Market Forecast and Analysis
7. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY WORKFLOW
7.1 Discovery Informatics
7.1.1 Overview
7.1.2 Discovery Informatics: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Drug Development
7.2.1 Overview
7.2.2 Drug Development: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SERVICE
8.1 Sequence Analysis Platform
8.1.1 Overview
8.1.2 Sequence Analysis Platform: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Modelling
8.2.1 Overview
8.2.2 Molecular Modelling: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Clinical Trial Data Management
8.3.1 Overview
8.3.2 Clinical Trial Data Management: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Docking
8.4.1 Overview
8.4.2 Docking: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY SOLUTIONS
9.1 Software
9.1.1 Overview
9.1.2 Software: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Services
9.2.1 Overview
9.2.2 Services: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET REVENUE ANALYSIS - BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Contract Research Organizations (CROs)
10.2.1 Overview
10.2.2 Contract Research Organizations (CROs): Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. MIDDLE EAST AND AFRICA DRUG DISCOVERY INFORMATICS MARKET - COUNTRY ANALYSIS
11.1 Middle East and Africa
11.1.1 Middle East and Africa Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Middle East and Africa Drug Discovery Informatics Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.1.2.2.2 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.1.2.2.3 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.1.2.2.4 Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.2.3.3 South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.2.3.3.2 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.2.3.3.3 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.2.3.3.4 South Africa: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.3.4.4 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.3.4.4.2 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.3.4.4.3 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.3.4.4.4 United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market Share - by End User
11.4.5.5 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Workflow
11.4.5.5.2 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Service
11.4.5.5.3 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by Solutions
11.4.5.5.4 Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market Share - by End User
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Dassault Systemes SE
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eurofins Scientific SE
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Jubilant Pharma Limited
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Revvity Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Certera
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Selvita
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Collaborative Drug Discovery, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Illumina, Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East and Africa Drug Discovery Informatics Market Segmentation
Table 2. List of Vendors
Table 3. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 5. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 6. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 7. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 10. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 11. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 12. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 14. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 15. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 16. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 18. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 19. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 20. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 22. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 23. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 24. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
Table 1. Middle East and Africa Drug Discovery Informatics Market Segmentation
Table 2. List of Vendors
Table 3. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 5. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 6. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 7. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 10. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 11. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 12. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 14. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 15. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 16. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 18. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 19. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 20. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Workflow
Table 22. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service
Table 23. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Solutions
Table 24. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East and Africa Drug Discovery Informatics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Drug Discovery Informatics Market
Figure 4. Middle East and Africa Drug Discovery Informatics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East and Africa Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Workflow, 2024 and 2031
Figure 8. Discovery Informatics: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Drug Development: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Service, 2024 and 2031
Figure 11. Sequence Analysis Platform: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Molecular Modelling: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Clinical Trial Data Management: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Docking: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Solutions, 2024 and 2031
Figure 17. Software: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Services: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East and Africa Drug Discovery Informatics Market Share (%) - by End User, 2024 and 2031
Figure 20. Pharmaceutical and Biotechnology Companies: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Contract Research Organizations (CROs): Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Middle East and Africa Drug Discovery Informatics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Company Positioning & Concentration
Figure 1. Middle East and Africa Drug Discovery Informatics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Drug Discovery Informatics Market
Figure 4. Middle East and Africa Drug Discovery Informatics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East and Africa Drug Discovery Informatics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Workflow, 2024 and 2031
Figure 8. Discovery Informatics: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Drug Development: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Service, 2024 and 2031
Figure 11. Sequence Analysis Platform: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Molecular Modelling: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Clinical Trial Data Management: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Docking: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Middle East and Africa Drug Discovery Informatics Market Share (%) - by Solutions, 2024 and 2031
Figure 17. Software: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Services: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East and Africa Drug Discovery Informatics Market Share (%) - by End User, 2024 and 2031
Figure 20. Pharmaceutical and Biotechnology Companies: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Contract Research Organizations (CROs): Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Others: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Middle East and Africa Drug Discovery Informatics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 24. Saudi Arabia: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. United Arab Emirates: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Rest of Middle East and Africa: Middle East and Africa Drug Discovery Informatics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Company Positioning & Concentration
